The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Hepatitis A in the Era of Vaccination
Abstract
The World Health Organization estimates an annual total of 1.5 million clinical cases of hepatitis A worldwide, but seroprevalence data indicate that tens of millions of hepatitis A virus infections occur each year. In the United States in the 1980s-1990s, an average of 26,000 acute hepatitis A cases were reported per year, representing approximately 270,000 infections annually. Since licensure of effective hepatitis A vaccines in the mid-1990s, US hepatitis A rates have fallen precipitously-particularly since 1999, when routine childhood vaccination was recommended in states with consistently elevated rates. By 2004, the overall rate had declined to 1.9/100,000 population, the lowest rate ever recorded and 79% lower than any previously recorded nadir. These marked declines occurred with relatively modest vaccination coverage, suggesting that strong herd immunity accompanies the initiation of routine vaccination programs. Routine childhood vaccination has produced similar results in Israel and selected regions of Italy, Spain, and Australia. Hepatitis A vaccination will probably remain a low priority for some time in the poorest countries, where most persons are infected as young children. However, shifts in the epidemiologic patterns of disease associated with declining hepatitis A virus transmission are occurring in many regions of the world. These shifts are likely to create circumstances where strategically targeted vaccination of children could produce substantial public health benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Principles and Practice of Infectious Diseases.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-1-169_2 · Cited by 1,564
(1999) · PsycEXTRA Dataset · doi:10.1037/e547812006-001 · Cited by 1,131
Vento, S., Garofano, T., Renzini, C., Cainelli, F., Casali, F., Ghironzi, G., Ferraro, T., & Concia, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380503 · Cited by 795
A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children
Werzberger, A., Mensch, B., Kuter, B., Brown, L., Lewis, J., Sitrin, R., Miller, W., Shouval, D., Wiens, B., Calandra, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208133270702 · Cited by 540
Protection Against Hepatitis A by an Inactivated Vaccine
Innis, B. L. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510410040030 · Cited by 417
A Multistate, Foodborne Outbreak of Hepatitis A
Hutin, Y. J. F., Pool, V., Cramer, E. H., Nainan, O. V., Weth, J., Williams, I. T., Goldstein, S. T., Gensheimer, K. F., Bell, B. P., Shapiro, C. N., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400802 · Cited by 387
An Epidemic of Hepatitis A Attributable to the Ingestion of Raw Clams in Shanghai, China
Halliday, M. L., Kang, L.-Y., Zhou, T.-K., Hu, M.-D., Pan, Q.-C., Fu, T.-Y., Huang, Y.-S., & Hu, S.-L. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.5.852 · Cited by 369
(2003) · Viral Infections and Treatment · doi:10.1201/b14823-11 · Cited by 361
Hepatitis A Transmitted by Food
Fiore, A. E. (2004) · Clinical Infectious Diseases · doi:10.1086/381671 · Cited by 352
Viral hepatitis. New light on an old disease
Krugman, S. (1970) · JAMA · doi:10.1001/jama.212.6.1019 · Cited by 348
FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTS
LEDNAR, W. M., LEMON, S. M., KIRKPATRICK, J. W., REDFIELD, R. R., FIELDS, M. L., & KELLEY, P. W. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114093 · Cited by 343
Hepatitis A in Day-Care Centers: A Community-Wide Assessment
Hadler, S. C., Webster, H. M., Erben, J. J., Swanson, J. E., & Maynard, J. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022203 · Cited by 300
THE PREVENTION AND ATTENUATION OF INFECTIOUS HEPATITIS BY GAMMA GLOBULIN: PRELIMINARY NOTE
STOKES, J. (1945) · Journal of the American Medical Association · doi:10.1001/jama.1945.02860030016004 · Cited by 290
Incidence of Hepatitis A in the United States in the Era of Vaccination
Wasley, A. (2005) · JAMA · doi:10.1001/jama.294.2.194 · Cited by 273
Self-citationIncidence of Hepatitis A in Israel Following Universal Immunization of Toddlers
Dagan, R. (2005) · JAMA · doi:10.1001/jama.294.2.202 · Cited by 261
Red Book: 2012 Report of the Committee on Infectious Diseases
Pickering, L. K. (2003) · Cited by 256
Mannucci, P. M., Gdovin, S., Gringeri, A., Colombo, M., Mele, A., Schinaia, N., Ciavarella, N., Emerson, S. U., Purcell, R. H., & and Italian Collaborative Group* (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00001 · Cited by 241
Hepatitis A booster vaccination: is there a need?
Van Damme, P., Banatvala, J., Fay, O., Iwarson, S., McMahon, B., Van Herck, K., Shouval, D., Bonanni, P., Connor, B., Cooksley, G., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14418-2 · Cited by 238
Bell, B. P., Shapiro, C. N., Alter, M. J., Moyer, L. A., Judson, F. N., Mottram, K., Fleenor, M., Ryder, P. L., & Margolis, H. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/314518 · Cited by 225
Clinical experience with an inactivated hepatitis A vaccine.
Clemens, R., Safary, A., Hepburn, A., Roche, C., Stanbury, W. J., & Andre, F. E. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s44 · Cited by 223 · cited 1×
“The lower limit of antibody required to prevent HAV infection has not been defined (45), but persons who develop anti-HAVabove this detection limit are considered to be protected from HAV infection (46, 47).”
BackgroundRelapsing Hepatitis A Review of 14 Cases and Literature Survey
Glikson, M., Galun, E., Oren, R., Tur-Kaspa, R., & Shouval, D. (1992) · MEDICINE · doi:10.1097/00005792-199201000-00002 · Cited by 216
A multifocal outbreak of hepatitis A traced to commercially distributed lettuce.
Rosenblum, L. S., Mirkin, I. R., Allen, D. T., Safford, S., & Hadler, S. C. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.9.1075 · Cited by 211
Armstrong, G. L., & Bell, B. P. (2002) · Pediatrics · doi:10.1542/peds.109.5.839 · Cited by 203
A multistate outbreak of hepatitis A caused by the consumption of raw oysters.
Desenclos, J. C., Klontz, K. C., Wilder, M. H., Nainan, O. V., Margolis, H. S., & Gunn, R. A. (1991) · American Journal of Public Health · doi:10.2105/ajph.81.10.1268 · Cited by 197
Rosenblum, L. S., Villarino, M. E., Nainan, O. V., Melish, M. E., Hadler, S. C., Pinsky, P. P., Jarvis, W. R., Ott, C. E., & Margolis, H. S. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.3.476 · Cited by 182
Epidemiology and Prevention of Hepatitis A in Travelers
Steffen, R. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520110065031 · Cited by 182
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial
Sagliocca, L., Amoroso, P., Stroffolini, T., Adamo, B., Tosti, M. E., Lettieri, G., Esposito, C., Buonocore, S., Pierri, P., & Mele, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08139-2 · Cited by 173
Hepatitis A Virus in Stool During Clinical Relapse
SJOGREN, M. H., TANNO, H., FAY, O., SILEONI, S., COHEN, B. D., BURKE, D. S., & FEIGHNY, R. J. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-221 · Cited by 171
Neilsen, G. A., Bodsworth, N., & Watts, N. (1997) · The Journal of Infectious Diseases · doi:10.1086/516512 · Cited by 143
Immunogenicity and protectivity of a new liposomal hepatitis A vaccine
Ambrosch, F. (1997) · Vaccine · doi:10.1016/s0264-410x(97)00015-7 · Cited by 140
Dagan, R., Amir, J., Mijalovsky, A., KALMANOVITCH, I., Bar-Yochai, A., Thoelen, S., Safary, A., & Ashkenazi, S. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200011000-00004 · Cited by 139
Staes, C. J., SCHLENKER, T. L., Risk, I., Cannon, K. G., Harris, H., Pavia, A. T., Shapiro, C. N., & Bell, B. P. (2000) · PEDIATRICS · doi:10.1542/peds.106.4.e54 · Cited by 138
Immunoglobulin prophylaxis for hepatitis A.
Winokur, P. L., & Stapleton, J. T. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.580 · Cited by 136 · cited 1×
“06 ml/kg protects for up to 5 months (37).”
BackgroundHost Immune Response To Hepatitis A Virus
Stapleton, J. T. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s9 · Cited by 129
The Persistence of Hepatitis A IgM Antibody After Acute Clinical Hepatitis A†
Kao, H. W., Ashcavai, M., & Redeker, A. G. (1984) · Hepatology · doi:10.1002/hep.1840040525 · Cited by 124
van Schaik, S. M., Obot, N., Enhörning, G., Hintz, K. H., Gross, K. J., Hancock, G. E., Stack, A. M., & Welliver, C. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200010)62:2<144::aid-jmv4>3.0.co;2-i · Cited by 117
Kemper, C. A., Haubrich, R., Frank, I., Dubin, G. O., Buscarino, C., McCutchan, J. A., Deresinski, S. C., & California Collaborative Treatment Group (2003) · The Journal of Infectious Diseases · doi:10.1086/374562 · Cited by 117
SAFETY AND EFFICACY OF HEPATITIS A VACCINATION IN LIVER TRANSPLANTATION RECIPIENTS1, 2
Arslan, M., Wiesner, R. H., Poterucha, J. J., & Zein, N. N. (2001) · Transplantation · doi:10.1097/00007890-200107270-00019 · Cited by 111
Immunogenicity and Safety of Hepatitis A Vaccine in Liver and Renal Transplant Recipients
Stark, K., Günther, M., Neuhaus, R., Reinke, P., Schröder, K., Linnig, S., & Bienzle, U. (1999) · The Journal of Infectious Diseases · doi:10.1086/315125 · Cited by 111
Hepatitis A Among Homosexual Men and Injection Drug Users: More Evidence for Vaccination
Villano, S. A., Nelson, K. E., Vlahov, D., Purcell, R. H., Saah, A. J., & Thomas, D. L. (1997) · Clinical Infectious Diseases · doi:10.1086/513757 · Cited by 106
Safety and Immunogenicity of an Inactivated Hepatitis A Vaccine among HIV-Infected Subjects
Wallace, M. R., Brandt, C. J., Earhart, K. C., Kuter, B. J., Grosso, A. D., Lakkis, H. D., & Tasker, S. A. (2004) · Clinical Infectious Diseases · doi:10.1086/424666 · Cited by 105
Immunogenicity of Hepatitis A Vaccine in Decompensated Liver Disease
Dumot, J. A., Barnes, D. S., Younossi, Z. M., Gordon, S. M., Avery, R. K., Domen, R. E., Henderson, M. J., & Carey, W. D. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01150.x · Cited by 104
Cotter, S. M., Sansom, S. L., Long, T., Koch, E., Kellerman, S., Smith, F., Averhoff, F. M., & Bell, B. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/374057 · Cited by 96
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants
Letson, G. W., Shapiro, C. N., Kuehn, D., Gardea, C., Welty, T. K., Krause, D. S., Lambert, S. B., & Margolis, H. S. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.11.030 · Cited by 96
McMahon, B. J., Williams, J. L., BULKOW, L. R., Snowball, M. M., Wainwright, R. B., Kennedy, M., & Krause, D. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.3.676 · Cited by 94
Nainan, O. V., Armstrong, G. L., Han, X., Williams, I., Bell, B. P., & Margolis, H. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/427992 · Cited by 91
Herck, K. V., & Damme, P. V. (2004) · New England Journal of Medicine · doi:10.1056/nejm200405203502121 · Cited by 83
Nalin, D. R., Kuter, B. J., Brown, L., PATTERSON, C. M., Calandra, G., Werzberger, A., Shouval, D., Ellerbeck, E. F., Block, S. L., Bishop, R., et al. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80379-4 · Cited by 78
Lemon, S. M. (1994) · Vox Sanguinis · doi:10.1111/j.1423-0410.1994.tb01293.x · Cited by 78
Tassopoulos, N., PAPAEVANGELOU, G. J., Ticehurst, J. R., & Purcell, R. H. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/154.2.231 · Cited by 77
Safety and immunogenicity of hepatitis A vaccine in healthy children
Horng, Y.-C., Chang, M., Lee, C., Safary, A., ANDRE, F. E., & Chen, D. (1993) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199305000-00001 · Cited by 77
Outbreaks of hepatitis A among illicit drug users, Oklahoma, 1984-87.
Harkess, J. R., Gildon, B., & Istre, G. R. (1989) · American Journal of Public Health · doi:10.2105/ajph.79.4.463 · Cited by 74
Fiore, A. E., Shapiro, C. N., Sabin, K. M., LABONTE, K., Darling, K., Culver, D. H., Bell, B. P., & Margolis, H. S. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000059446.52063.b9 · Cited by 74
Hepatitis A vaccine: Indirect evidence of immune memory 12 years after the primary course
Herck, K. V., Damme, P. V., Lievens, M., & Stoffel, M. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10574 · Cited by 73
Comparison of immunogenicity of two hepatitis A vaccines — VAQTA® and HAVRIX® — in young adults
Ashur, Y., Adler, R., Rowe, M., & Shouval, D. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00480-0 · Cited by 73
Bríem, H., & Safary, A. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440424 · Cited by 66
HEPATITIS A, B, AND DELTA INFECTION IN ETHIOPIA: A SEROLOGIC SURVEY WITH DEMOGRAPHIC DATA
Tsega, E., MENGESHA, B., Hansson, B. G., LINDBERG, J., & Nordenfelt, E. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114243 · Cited by 65
Six Years' Follow-up after Hepatitis A Vaccination
Werzberger, A., Kuter, B. J., & Nalin, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804163381615 · Cited by 64
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines
Bryan, J. P., Henry, C. H., Hoffman, A. G., South-Paul, J. E., Smith, J. A., Cruess, D. F., Spieker, J., & de Medina, M. D. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00301-7 · Cited by 59
Safety And Immunogenicity Of An Inactivated Hepatitis A Vaccine In Preschool Children
Balcarek, K. B., Bagley, M. R., Pass, R. F., Schiff, E. R., & Krause, D. S. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_1.s70 · Cited by 59
Response to hepatitis A vaccine in HIV patients in the HAART era
Rimland, D., & Guest, J. L. (2005) · AIDS · doi:10.1097/01.aids.0000186815.99993.55 · Cited by 57
Czeschinski, P. A. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00354-0 · Cited by 57
Poovorawan, Y., Theamboonlers, A., Chongsrisawat, V., Jantaradsamee, P., Chutsirimongkol, S., & Tangkijvanich, P. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.04.008 · Cited by 55
Wagner, G., Lavanchy, D., Darioli, R., Pécoud, A. R., Brulein, V., Safary, A., & Frei, P. C. (1993) · Vaccine · doi:10.1016/0264-410x(93)90128-k · Cited by 54
Immunologic approaches to assessing the response to inactivated hepatitis A vaccine
Lemon, S. M. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80372-1 · Cited by 52
Immunogenicity and Safety of Hepatitis A Vaccine in Children With Chronic Liver Disease
Ferreira, C. T., da Silveira, T. R., Vieira, S. M. G., Taniguchi, A. N. R., & Pereira‐Lima, J. (2003) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200309000-00011 · Cited by 50
Iwarson, S. A., Lindh, M., & Widerström, L. (2006) · Journal of Travel Medicine · doi:10.2310/7060.2004.17079 · Cited by 48
Williams, J. L., Bruden, D. J. T., Cagle, H. H., McMahon, B. J., Negus, S. E., Christensen, C. J., Snowball, M. M., BULKOW, L. R., & Fox-Leyva, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00250-0 · Cited by 46
Rise in the Incidence of Viral Hepatitis in Israel Despite Improved Socioeconomic Conditions
Green, M. S., Block, C., & Slater, P. E. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.464 · Cited by 46
Kinetics of maternal hepatitis a antibody decay in infants: implications for vaccine use
Lieberman, J. M., Chang, S., Partridge, S., Hollister, J. C., Kaplan, K. M., Jensen, E. H., Kuter, B. J., & Ward, J. I. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200204000-00017 · Cited by 45
Vong, S., Fiore, A. E., Haight, D. O., Li, J., Borgsmiller, N., Kuhnert, W. L., Pinero, F., Boaz, K., Badsgard, T., Mancini, C., et al. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.07.038 · Cited by 44
Immunogenicity and Tolerability of Hepatitis A Vaccine in HIV-Infected Children
Gouvêa, A. D. F. T. B., de Moraes‐Pinto, M. I., Ono, É., Dinelli, M. I. S., Machado, D. M., Weckx, L. Y., & Succi, R. C. M. (2005) · Clinical Infectious Diseases · doi:10.1086/432055 · Cited by 40
World Atlas of Epidemic Diseases
Cliff, A. D., Haggett, P., & Smallman-Raynor, M. R. (2004) · Bristol Research (University of Bristol) · Cited by 38
Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults
Walter, E. B. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00370-3 · Cited by 36
Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults
Knöll, A., Hottenträger, B., Kainz, J., Bretschneider, B., & Jilg, W. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00524-1 · Cited by 34
Hepatitis A booster vaccine in children after infant immunization
Kanra, G., YALÇIN, S. S., Kara, A., Özmert, E. N., & Yurdakök, K. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200208000-00006 · Cited by 30
Immunogenicity of Inactivated Hepatitis A Vaccine in Children With Chronic Liver Disease
Majda-Stanisławska, E., Bednarek, M., & Kuydowicz, J. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000130076.33497.6c · Cited by 25
Connor, B. A., Phair, J., Sack, D. A., McEniry, D., Hornick, R. B., Banerjee, D., Jensen, E., & Kuter, B. J. (2001) · Clinical Infectious Diseases · doi:10.1086/318522 · Cited by 23
Usonis, V., Meriste, S., Bakasénas, V., Lutsar, I., Collard, F., Stoffel, M., & Tornieporth, N. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.062 · Cited by 23
Lemon, S. M. (1994) · Vox Sanguinis · doi:10.1159/000462759 · Cited by 15
Robertson, B. H., & Bell, B. P. (2003) · Wiley eBooks · doi:10.1038/npg.els.0001026 · Cited by 14
Cited by
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Bernal, W., Auzinger, G., Dhawan, A., & Wendon, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60274-7 · Cited by 996
Hepatitis B: Epidemiology and prevention in developing countries
Franco, E. (2012) · World Journal of Hepatology · doi:10.4254/wjh.v4.i3.74 · Cited by 577
Hepatitis A virus seroprevalence by age and world region, 1990 and 2005
Jacobsen, K. H., & Wiersma, S. T. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.037 · Cited by 569
Barreto, M. L., Teixeira, M. G., Bastos, F. I., Ximenes, R. A., Barata, R. B., & Rodrigues, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60202-x · Cited by 396
Metadata
- Authors
- Wasley, A.
- Venue
- Epidemiologic Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-06-01
- Volume
- 28
- Issue
- 1
- Pages
- 101-111
- ISSN
- 0193-936X (ISSN-L)
- 1478-6729
- OpenAlex
- W2111799124
- Cited by
- 295
- References
- 85
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.